· 2 min read
Laser Light Shown to Trigger Site-Specific Chemical Tagging of DNA Strands
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer
· 2 min read
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Based on the PubMed abstract — the full text of this paper was not freely available.
This 1989 paper by Oshevskiĭ, published in the journal Bioorganicheskaia khimiia, is a laboratory chemistry study about controlling exactly where a reactive chemical group attaches to a DNA strand. It is not a biology, skin or health study.
The author built a short synthetic strand of DNA-like material (an oligonucleotide) carrying an attached chemical group derived from nitrogen mustard, a compound that can react with and bond to other molecules once activated. Normally this group is switched on through a mild chemical step called borohydride reduction, acting on part of the molecule called an aromatic formyl group. The paper reports that the same switching-on can instead be achieved using nitrogen laser light at a wavelength of 337 nanometres.
When this reagent strand was paired with a target strand of polydeoxyribonucleotide — the chemical name for a chain of DNA building blocks — activating it by either method caused a chemical change at a specific point on the target. The exact position that got modified differed depending on whether the chemical or the laser method was used.
The paper, known only from its abstract, reports no results in cells, tissue, or living organisms, and nothing about biological effects, safety, or skin-related outcomes.
Our reflection
This is an example of foundational, unrelated DNA chemistry from decades ago, built around laboratory reagents and targeted activation methods rather than biology or skin science. At Havdis, we think there is value in documenting the full breadth and history of nucleic-acid research as context, even where a given paper, like this one, has no direct bearing on today's applications.
Source
Oshevskiĭ SN (1989). Bioorganicheskaia khimiia.
This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.
Related
A 1993 European Journal of Pharmacology study on how defibrotide, a polydeoxyribonucleotide, binds adenosine A1 and A2 receptors in lab experiments.
Read more →A 1992 study on how X-irradiation alters nuclease enzyme activity in rat thymocyte cell nuclei, generating polydeoxyribonucleotide fragments.
Read more →1992 Life Sciences study on how defibrotide, a PDRN sodium salt, may fight blood clots via free-radical scavenging and immune cell modulation.
Read more →